1. Home
  2. CNK vs FOLD Comparison

CNK vs FOLD Comparison

Compare CNK & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cinemark Holdings Inc Cinemark Holdings Inc.

CNK

Cinemark Holdings Inc Cinemark Holdings Inc.

HOLD

Current Price

$24.59

Market Cap

3.3B

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$10.17

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNK
FOLD
Founded
1984
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.1B
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
CNK
FOLD
Price
$24.59
$10.17
Analyst Decision
Strong Buy
Buy
Analyst Count
10
7
Target Price
$35.30
$30.29
AVG Volume (30 Days)
4.4M
4.2M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
1.30%
N/A
EPS Growth
N/A
N/A
EPS
1.11
N/A
Revenue
$3,153,000,000.00
$598,704,000.00
Revenue This Year
$6.71
$21.49
Revenue Next Year
$7.78
$18.25
P/E Ratio
$22.08
N/A
Revenue Growth
9.70
21.28
52 Week Low
$21.62
$5.51
52 Week High
$34.01
$10.79

Technical Indicators

Market Signals
Indicator
CNK
FOLD
Relative Strength Index (RSI) 40.79 75.23
Support Level $21.62 $9.73
Resistance Level $25.57 $10.05
Average True Range (ATR) 1.32 0.37
MACD -0.21 0.01
Stochastic Oscillator 36.18 99.54

Price Performance

Historical Comparison
CNK
FOLD

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: